Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma
Authors
Keywords
-
Journal
Cancer Medicine
Volume 7, Issue 5, Pages 1670-1679
Publisher
Wiley
Online
2018-03-24
DOI
10.1002/cam4.1390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modeling the benefits and harms of surveillance for hepatocellular carcinoma: Information to support informed choices
- (2017) Eleanor J. Taylor et al. HEPATOLOGY
- MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice
- (2017) Heng Wu et al. HEPATOLOGY
- Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients
- (2017) Meike H. van der Ree et al. JOURNAL OF INFECTIOUS DISEASES
- Role of exosomal proteins in cancer diagnosis
- (2017) Weihua Li et al. Molecular Cancer
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges
- (2017) Nicholas L. Syn et al. TRENDS IN BIOTECHNOLOGY
- Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
- (2017) Haiyang Zhang et al. Nature Communications
- Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B
- (2017) Ming-Ming Tian et al. Clinics and Research in Hepatology and Gastroenterology
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells
- (2016) Stella Chai et al. HEPATOLOGY
- Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation
- (2016) Kevin Tak-Pan NG et al. Oncotarget
- ExtraPEG: A Polyethylene Glycol-Based Method for Enrichment of Extracellular Vesicles
- (2016) Mark A. Rider et al. Scientific Reports
- Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation
- (2015) K Sugimachi et al. BRITISH JOURNAL OF CANCER
- Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells
- (2015) Jin-xing Wei et al. HEPATOLOGY
- miRNA for diagnosis and clinical implications of human hepatocellular carcinoma
- (2015) Yurong Wang et al. HEPATOLOGY RESEARCH
- miR-122 – A key factor and therapeutic target in liver disease
- (2015) Simonetta Bandiera et al. JOURNAL OF HEPATOLOGY
- Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
- (2015) Sonia A. Melo et al. NATURE
- p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB
- (2015) QUAN ZHANG et al. ONCOLOGY REPORTS
- Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma
- (2015) Feng Wang et al. TUMOR BIOLOGY
- Down-expression of miR-152 lead to impaired anti-tumor effect of NK via upregulation of HLA-G
- (2015) Xiaokun Bian et al. TUMOR BIOLOGY
- Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
- (2015) Francesca Fornari et al. PLoS One
- microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression
- (2015) Mi Jeong Heo et al. Oncotarget
- Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells
- (2014) Nami Yamada et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma
- (2014) Zhao Sun et al. BMC CANCER
- The emerging roles of microvesicles in liver diseases
- (2014) Sara Lemoinne et al. Nature Reviews Gastroenterology & Hepatology
- Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
- (2012) C I Jones et al. BRITISH JOURNAL OF CANCER
- MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway
- (2012) Jie Xu et al. LIVER INTERNATIONAL
- Molecular classification of hepatocellular carcinoma anno 2011
- (2011) H. van Malenstein et al. EUROPEAN JOURNAL OF CANCER
- Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
- (2011) Peng Qi et al. PLoS One
- Serum microRNA characterization identifiesmiR-885-5pas a potential marker for detecting liver pathologies
- (2010) Junhao Gui et al. CLINICAL SCIENCE
- Optimization of imaging diagnosis of 1–2cm hepatocellular carcinoma: An analysis of diagnostic performance and resource utilization
- (2010) Korosh Khalili et al. JOURNAL OF HEPATOLOGY
- Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
- (2010) Jian Xu et al. MOLECULAR CARCINOGENESIS
- Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
- (2009) Guilherme Rabinowits et al. Clinical Lung Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started